Modeling device and method for preparing multiple cerebral infarction from soft autologous blood microembolus

A technology of microemboli and autologous blood, which is applied in animal husbandry and other fields, can solve the problems of blood vessel rupture, high mortality rate of craniotomy, and large trauma, and achieve the effect of accelerated mold-making speed, low mortality rate, and small injury

Pending Publication Date: 2022-06-03
CHENGDE MEDICAL UNIV
View PDF7 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The disadvantage is that the insertion process is easy to cause blood vessel rupture, subarachnoid hemorrhage, etc., resulting in high mortality of experimental animals, and the thread embolization method requires a high level of proficiency in the operation of the experimenter.
Surgical methods include electrocautery of part of the middle cerebral artery and injection of vasoconstrictor through brain stereotaxic craniotomy to cause multiple cerebral infarctions. The surgical method can enter the area closer to the middle cerebral artery, but the disadvantage is that the mortality rate of craniotomy is high, Highly traumatic, and the injected drug dose has a great impact
Embolus injection method, the embolus injection method used today is the method of taking blood and drying it into granules. The embolus produced by this method has the disadvantages of high hardness and high probability of autolysis.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Modeling device and method for preparing multiple cerebral infarction from soft autologous blood microembolus
  • Modeling device and method for preparing multiple cerebral infarction from soft autologous blood microembolus
  • Modeling device and method for preparing multiple cerebral infarction from soft autologous blood microembolus

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0044] The molding step of the present invention

[0045] 1. 20 male Sprague-Dawley rats were injected with carrageenan-coated autologous hematopoietic microemboli, and designated as the model group. Another 20 rats underwent the same operation, but without microemboli injection, and were designated as the sham group.

[0046] S1: Put the rat in the anesthesia guide box, open the regulating valve and inject isoflurane, and perform rapid gas anesthesia. After the rat is anesthetized, quickly remove the capillary used for blood collection in the right hand, press the rat's head with the left hand and use the left thumb and The index finger opened the upper eyelid and lower eyelid of the rat to make the eyeball protrude. In the right hand, the capillary was inclined from the inner corner of the eye while rotating and inserted into the medial canthal vein, and the capillary was inclined downward to fill the entire capillary with blood.

[0047] S2: After the blood collection, use...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a multiple cerebral infarction modeling device and method prepared from soft autologous blood microembolus, and relates to the field of animal modeling. The method comprises the following steps: injecting autologous blood soft microembolus coated with carrageenan into the brain of a rat through an external carotid artery, establishing a multiple cerebral infarction animal model, detecting cerebral infarction disease related experimental markers, observing pathological changes of brain tissues, neuronal structure changes and generation of spatial behavior dysmnesia, and establishing a multiple cerebral infarction animal model. Comprising the steps of red tetrazole staining, hematoxylin-eosin staining, immunohistochemistry, water maze and Bass maze. The rat model proves that the rat has spatial behavior memory disorder, neurons and brain tissues have pathological mechanism changes, and an animal model with similar pathogenesis processes is provided for researching clinical multiple cerebral infarction. The establishment of the animal model has an important value for deepening the treatment research of multiple cerebral infarction diseases.

Description

technical field [0001] The invention relates to the field of animal modeling, in particular to a modeling device and method for preparing multiple cerebral infarction from soft autologous blood microemboli. Background technique [0002] Cerebral infarction is well known for its high mortality, morbidity, and disability rates. Multiple cerebral infarction is another type with a higher proportion. Clinical patients often have functional impairments such as language, behavior, and memory, as well as clinical manifestations such as deviated mouth and eyes, salivation, slurred speech, and inability to stretch and walk normally. Among the general pathological changes, brain tissue softening, necrosis, multiple infarcts, and neuronal loss and structural changes are common. According to research, the risk factors of multiple cerebral infarction are related to many factors including neuroinflammation, cranial aortic atherosclerosis and plaque shedding, and abnormal serum levels of ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A01K67/02
CPCA01K67/02
Inventor 吴晓光商亚珍于静
Owner CHENGDE MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products